搜索临床试验以:Androgen Receptor-positive
总计1809个结果
-
Arvinas Inc.招聘中复发/难治性 (R/R) 成熟 B 细胞非霍奇金淋巴瘤 (NHL) | 复发/难治性 (R/R) 血管免疫母细胞 T 细胞淋巴瘤 (AITL)美国, 西班牙
-
Qian QinJanssen, LP; UT Southwestern Comprehensive Cancer Center尚未招聘BRCA1基因突变 | BRCA2基因突变 | BRIP1基因突变 | PALB2基因突变 | CHEK2基因突变 | FANCA基因突变 | RAD51B基因突变 | RAD54L基因突变 | 转移性激素敏感性前列腺癌 (mHSPC) | 有害的 HRR 基因突变
-
Mayo Clinic尚未招聘复发性前列腺癌 | 去势抵抗性前列腺癌 | IVB 期前列腺癌 AJCC v8 | 复发性去势敏感前列腺癌美国
-
Universitaire Ziekenhuizen KU LeuvenEli Lilly and Company; Kom Op Tegen Kanker; Teva Pharma招聘中
-
The First Affiliated Hospital with Nanjing Medical...招聘中
-
Peking University First HospitalJiangsu Hengrui Pharmaceutical Co., Ltd.; Beijing Biote Pharmaceutical Co.,Ltd招聘中
-
University of Sao Paulo General Hospital尚未招聘绝经 | 睾酮缺乏症 | 雌激素缺乏
-
Ohio State University Comprehensive Cancer CenterPfizer; Myovant Sciences GmbH; Sumitomo Pharmaceuticals America尚未招聘
-
University College, LondonNovartis; Cancer Research UK; Janssen Pharmaceutica NV尚未招聘
-
University of WashingtonWashington State University尚未招聘
-
Pedro Barata, MD, MScESSA Pharma Inc.尚未招聘
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...招聘中
-
Roswell Park Cancer Institute招聘中
-
M.D. Anderson Cancer CenterJanssen Scientific Affairs, LLC尚未招聘前列腺癌 | 前列腺切除术 | 雄激素轴抑制美国
-
Central Finland Hospital DistrictTampere University; Tampere University Hospital; University of Jyvaskyla尚未招聘
-
AI Labs Group S.LInstituto de Dermatología Integral (IDEI)招聘中
-
University of Wisconsin, MadisonNational Heart, Lung, and Blood Institute (NHLBI)招聘中
-
Northwestern UniversityNational Cancer Institute (NCI)招聘中
-
Azienda Unità Sanitaria Locale Reggio Emilia招聘中
-
Second Affiliated Hospital, School of Medicine,...招聘中
-
University of Maryland, BaltimoreJanssen Scientific Affairs, LLC招聘中
-
Mayo Clinic招聘中生化复发性前列腺癌 | IV 期前列腺癌 AJCC v8 | IIC 期前列腺癌 AJCC v8 | III 期前列腺癌 AJCC v8 | IIB 期前列腺癌 AJCC v8 | 寡转移性前列腺癌 | 复发性前列腺癌美国
-
University of Southern CaliforniaNational Cancer Institute (NCI)招聘中
-
The First Affiliated Hospital with Nanjing Medical...招聘中
-
Mamta ParikhNational Cancer Institute (NCI)招聘中